Private-pay lab turnkey model for physician practices
Recorded opinion date:
The commentary below transcribes Cabra's existing summary PDF. It preserves the original analysis, including its checklist and wording. The original PDF remains available below. Advisory opinions concern their particular facts and requestors; this commentary is not legal advice.
What OIG Said
Even with FMV terms and a federal carve-out, a “low-risk profit opportunity” can still be viewed as remuneration tied to federal referrals.
⚠OIG reviewed a proposal where a parent lab would form a management company to lease space, equipment, personnel, and lab management/support to physician groups so they could run their own physician-group labs for non-Federal patients only.
⚠OIG emphasized that carving out Federal business is not dispositive; questionable private-pay economics can still disguise or induce Federal referrals.
⚠Even if lease/management/license fees are fixed and FMV, OIG saw the arrangement as giving physicians a potentially lucrative, low-or-no-risk expansion into lab profits, which is “something of value” that can influence downstream federal ordering.
⚠OIG could not rule out a nexus between private-pay lab profits and increased Federal specimen referrals (e.g., convenience, loyalty, or blurred operational lines), and flagged overutilization risk for all patients.
OIG WATCH | info@cabraconsulting.com
Diligence Checklist
What you need to be ready to show in diligence
✓Show that any leasing/management/support model does not create a profit opportunity that depends on or is designed to influence Federal referrals.
✓If using carve-outs, prove they are operationally real and independently managed—not just paper distinctions that still steer federal testing.
✓Have comprehensive FMV support for every payment stream, but recognize FMV alone won’t save a structure that creates referral-linked incentives.
✓Document clinical and commercial rationale for any ancillary profit center tied to physician ordering behavior; diligence will test for inducement and utilization drift.
If your “private-pay only” side venture still creates value that can sway Federal ordering, this is the profile OIG said will draw fire
OIG WATCH | info@cabraconsulting.com
Structure not diligence-ready?
Cabra Consulting helps healthcare organizations make sure compensation and transaction structures are independently valued, clearly scoped, and defensible in diligence.
OIG WATCH | info@cabraconsulting.com
Original PDF cover text
UNFAVORABLE
OIG WATCH
13-03
Private-pay lab turnkey model for physician practices
Cabra commentary publication date is not recorded in the existing source. No publication or revision date has been inferred from this HTML conversion.
The commentary below transcribes Cabra's existing summary PDF. It preserves the original analysis, including its checklist and wording. The original PDF remains available below. Advisory opinions concern their particular facts and requestors; this commentary is not legal advice.
What OIG Said
Even with FMV terms and a federal carve-out, a “low-risk profit opportunity” can still be viewed as remuneration tied to federal referrals.
⚠OIG reviewed a proposal where a parent lab would form a management company to lease space, equipment, personnel, and lab management/support to physician groups so they could run their own physician-group labs for non-Federal patients only.
⚠OIG emphasized that carving out Federal business is not dispositive; questionable private-pay economics can still disguise or induce Federal referrals.
⚠Even if lease/management/license fees are fixed and FMV, OIG saw the arrangement as giving physicians a potentially lucrative, low-or-no-risk expansion into lab profits, which is “something of value” that can influence downstream federal ordering.
⚠OIG could not rule out a nexus between private-pay lab profits and increased Federal specimen referrals (e.g., convenience, loyalty, or blurred operational lines), and flagged overutilization risk for all patients.
OIG WATCH | info@cabraconsulting.com
Diligence Checklist
What you need to be ready to show in diligence
✓Show that any leasing/management/support model does not create a profit opportunity that depends on or is designed to influence Federal referrals.
✓If using carve-outs, prove they are operationally real and independently managed—not just paper distinctions that still steer federal testing.
✓Have comprehensive FMV support for every payment stream, but recognize FMV alone won’t save a structure that creates referral-linked incentives.
✓Document clinical and commercial rationale for any ancillary profit center tied to physician ordering behavior; diligence will test for inducement and utilization drift.
If your “private-pay only” side venture still creates value that can sway Federal ordering, this is the profile OIG said will draw fire
OIG WATCH | info@cabraconsulting.com
Structure not diligence-ready?
Cabra Consulting helps healthcare organizations make sure compensation and transaction structures are independently valued, clearly scoped, and defensible in diligence.
OIG WATCH | info@cabraconsulting.com
Original PDF cover text
UNFAVORABLE
OIG WATCH 13-03
Private-pay lab turnkey model for physician practices
Cabra commentary publication date is not recorded in the existing source. No publication or revision date has been inferred from this HTML conversion.